Effectiveness of a controlled 5-fu delivery based on fzd10 antibody-conjugated liposomes in colorectal cancer in vitro models

HIGHLIGHTS

• who: Maria Principia Scavo and collaborators from the Personalized Medicine Laboratory, National Institute of Gastroenterology "SdeBellis", Via Turi , Castellana Grotte, Bari, Italy Department of Pharmacy-Drug Science, University of Bari, Via EOrabona, Bari, Italy have published the Article: Effectiveness of a Controlled 5-FU Delivery Based on FZD10 Antibody-Conjugated Liposomes in Colorectal Cancer In Vitro Models, in the Journal: Pharmaceutics 12,were x deviation.2020, Data of /2020/

SUMMARY

For the preparation of 5-FU/LPs conjugated with FZD10 antibody (anti-FZD10/5-FU/LPs), 5-FU/LPs were previously surface-functionalized . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.